The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option

Author： Kashyap Mahendra   Tyagi Pradeep  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.5, 2013-05, pp. : 617-627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mirabegron in the treatment of overactive bladder

By Leone Roberti Maggiore Umberto   Cardozo Linda   Ferrero Simone   Sileo Filomena   Cola Alice   Torella Marco   Colacurci Nicola   Candiani Massimo   Salvatore Stefano  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 873-887

Informa Healthcare

Access to resources Recommend Favorite

Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence

By Sacco Emilio   Bientinesi Riccardo   Tienforti Daniele   Racioppi Marco   Gulino Gaetano   D'Agostino Daniele   Vittori Matteo   Bassi Pierfrancesco  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 4, 2014-04 ,pp. : 433-448

Informa Healthcare

Access to resources Recommend Favorite

Extended-release oxybutynin an effective option in overactive bladder

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Overactive bladder: drug therapy reduces resource use

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 363, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Extended-release tolterodine is an effective and convenient option in the treatment of overactive bladder

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 2, 2005-02 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite